The Europe Optical Imaging Market would witness market growth of 12.4% CAGR during the forecast period (2022-2028).
Fluorescence imaging is crucial in preclinical settings for researching drug-mediated protein-protein interactions in vivo and cell culture. In vitro or cell culture, drug-induced protein interactions may be seen and measured. This enables high-throughput content screening of substances, including toxicity, mechanistic investigations, the clarification of molecular function, and the identification of new biologic drugs. The approach is broadened to visualize medication impacts on tumor angiogenesis, apoptosis, and growth. The da Vinci (Intuitive Surgical), Artemis (innoMedicus), and Stryker fluorescence imaging vision systems are examples of vision systems built on fluorescent cameras used to perform robotic surgery in clinical settings.
The fluorescent process involves the absorption of light from various sources by tissues, followed by some of this light's emission a few nanoseconds later, which is detected by multiple detectors. To distinguish the emitted light from the excitation light is the goal. Using experimental intensity values from each source-detector, a light propagation model is compared with the results based on the distribution of scattering and absorption characteristics. As a result, the development of optical filters, filter cubes, and dichroic mirrors, as well as their relationship to one another, is essential for the effective imaging of contrast agents.
Germany has a robust healthcare system, particularly regarding hospital beds, infrastructure, and skilled personnel. In Germany, the healthcare industry accounts for one in every six employees and has an economic impact of EUR 678.2 billion (USD 798 billion) or around 12% of Germany's GDP. HCT generates EUR 131.2 billion (USD 154.4 billion) in overseas sales, accounting for 8.3% of Germany's exports. The German medical equipment industry is predicted to grow at a CAGR of 5.1 percent in euro terms and 6.8 percent in US dollar terms from 2020 to 2025. The robust healthcare sector in the region joined with the constant development, will increase the utilization of optical imaging techniques to provide better care to the population and hence boost the market growth in Europe.
The Germany market dominated the Europe Optical Imaging Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $200.6 Million by 2028. The UK market is anticipated to grow at a CAGR of 11.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 13.2% during (2022 - 2028).
Based on Product, the market is segmented into Imaging Systems, Illuminating Systems, Camera, Software and Lenses & Others. Based on End User, the market is segmented into Hospitals & Clinics, Research Laboratories and Pharmaceutical & Biotechnology Companies. Based on Technique, the market is segmented into Optical Coherence Tomography, Near Infrared Spectroscopy, Hyperspectral Imaging and Photoacoustic Tomography. Based on Application, the market is segmented into Pathological Imaging and Intraoperative Imaging. Based on Therapeutic Area, the market is segmented into Oncology, Ophthalmology, Cardiology, Dermatology, Neurology and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Optical Imaging Market is Projected to reach USD 3.1 Billion by 2028, at a CAGR of 13.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Carl Zeiss AG, Leica Microsystems GmbH (Danaher Corporation), Abbott Laboratories, Canon, Inc. (Canon Medical Systems Corporation), PerkinElmer, Inc., Topcon Corporation, Hamamatsu Photonics K.K., Koninklijke Philips N.V., Heidelberg Engineering, Inc. and Visionix Ltd.
By Product
By End User
By Technique
By Application
By Therapeutic Area
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
